Literature DB >> 6441659

Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection.

C P Maury, A M Teppo.   

Abstract

The effect of renal allograft rejection on the concentrations of the amyloid-related protein SAA, C-reactive protein (CRP), and beta 2-microglobulin (beta 2m) were compared, and the usefulness of post-transplant monitoring of these proteins in rejection diagnosis was evaluated. On the basis of the data from 30 reversible allograft rejections, the SAA test in rejection diagnosis was found to be more useful than either the beta 2m or CRP tests. The dramatic rejection-induced SAA elevation made it possible to choose a limit value for the SAA test that combined high sensitivity with reasonably high specificity. In contrast, limit values for beta 2m or CRP giving high sensitivity were combined with relatively low specificity. It is concluded that while post-transplant monitoring of SAA, CRP and beta 2m can all provide useful information aiding the early recognition and verification of acute allograft rejection, the properties of SAA are best suited for the purpose of a rejection marker.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441659

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  10 in total

Review 1.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.

Authors:  M Uguccioni; R Meliconi; E Lalli; S Nesci; C Delfini; G Lucarelli; G Gasbarrini; A Facchini
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

3.  Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis.

Authors:  T Yamada; Y Okuda; K Takasugi; K Itoh; J Igari
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

4.  Acute phase response in cerebral infarction.

Authors:  J Syrjänen; A M Teppo; V V Valtonen; M Iivanainen; C P Maury
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

5.  Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

Authors:  C P Maury; L C Andersson; A M Teppo; S Partanen; E Juvonen
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

6.  Antibodies to amyloid A protein in rheumatic diseases.

Authors:  C P Maury; A M Teppo
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

7.  Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases.

Authors:  C P Maury
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

Review 8.  Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers.

Authors:  Sunil Kurian; Yevgeniy Grigoryev; Steve Head; Daniel Campbell; Tony Mondala; Daniel R Salomon
Journal:  Int Immunopharmacol       Date:  2007-08-09       Impact factor: 4.932

9.  Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone.

Authors:  J W Smith; T L McDonald
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

10.  Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction.

Authors:  C P Maury; K J Tötterman; C G Gref; C Ehnholm
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.